arginyl-glycyl-aspartic acid has been researched along with melphalan in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Corti, A; Monaco, L; Zarovni, N | 1 |
Fullerton, N; Golas, AR; Hooper, RC; Lekic, N; Perez, JL; Spector, JA | 1 |
2 other study(ies) available for arginyl-glycyl-aspartic acid and melphalan
Article | Year |
---|---|
Inhibition of tumor growth by intramuscular injection of cDNA encoding tumor necrosis factor alpha coupled to NGR and RGD tumor-homing peptides.
Topics: Animals; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; DNA, Complementary; Doxorubicin; Endothelium, Vascular; Feedback, Physiological; Female; Genetic Therapy; Injections, Intramuscular; Lymphoma, T-Cell; Melanoma, Experimental; Melphalan; Mice; Mice, Inbred C57BL; Oligopeptides; Peptide Fragments; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2004 |
Vascular smooth muscle cell optimization of vasculogenesis within naturally derived, biodegradable, hybrid hydrogel scaffolds.
Topics: Alginates; Biocompatible Materials; Cell Adhesion; Chitosan; Coculture Techniques; Collagen Type I; Endothelial Cells; Fibroblast Growth Factor 2; Human Umbilical Vein Endothelial Cells; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Immunoglobulin G; Melphalan; Muscle, Smooth, Vascular; Neovascularization, Physiologic; Oligopeptides; Paracrine Communication; Tissue Engineering; Tissue Scaffolds | 2013 |